Cleo Diagnostics (ASX:COV) FCF Margin %: 0.00% (As of Dec. 2025)


ASX:COV Cleo Diagnostics Ltd ASX:COV
17 GF Score
Price A$0.48
! 1 Warning Sign
View Full Analysis

What is Cleo Diagnostics FCF Margin %?

Cleo Diagnostics ASX:COV 17 FCF Margin % is 0.00% as of Dec. 2025. GuruFocus rates ASX:COV with a GF Score™ of 17/100. The stock has 1 warning sign investors should review. Among 815 Medical Devices & Instruments companies, Cleo Diagnostics ranks worse than 122699.26% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Cleo Diagnostics's Free Cash Flow for the six months ended in Dec. 2025 was A$-1.67 Mil. Cleo Diagnostics's Revenue for the six months ended in Dec. 2025 was A$0.00 Mil. Therefore, Cleo Diagnostics's FCF Margin % for the quarter that ended in Dec. 2025 was 0.00%.

As of today, Cleo Diagnostics's current FCF Yield % is -3.87%.

The historical rank and industry rank for Cleo Diagnostics's FCF Margin % or its related term are showing as below:


ASX:COV's FCF Margin % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: -0.03
* Ranked among companies with meaningful FCF Margin % only.

Cleo Diagnostics FCF Margin % Related Terms

Cleo Diagnostics FCF Margin % Historical Data

* Premium members only.

The historical data trend for Cleo Diagnostics's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cleo Diagnostics FCF Margin % Chart

Cleo Diagnostics Annual Data
Trend Jun23 Jun24 Jun25
FCF Margin %
0.00 0.00 0.00

Cleo Diagnostics Semi-Annual Data
Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
FCF Margin % Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

ASX:COV vs ABT, SYK, MDT: FCF Margin % Comparison

For the Medical Devices subindustry, Cleo Diagnostics's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cleo Diagnostics FCF Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Cleo Diagnostics's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Cleo Diagnostics's FCF Margin % falls into.


ASX:COV
17GF Score
Cleo Diagnostics Ltd ASX:COV
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cleo Diagnostics FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Cleo Diagnostics's FCF Margin for the fiscal year that ended in Jun. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Jun. 2025 )/Revenue (A: Jun. 2025 )
=-2.912/0
= %

Cleo Diagnostics's FCF Margin for the quarter that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-1.67/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
Cleo Diagnostics (ASX:COV) has a FCF Margin % of 0.00% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Cleo Diagnostics and its competitors. According to the industry distribution chart, Cleo Diagnostics ranks #999999 out of 815 companies in the Medical Devices & Instruments industry.
Is Cleo Diagnostics' FCF Margin % too high?
Cleo Diagnostics' current FCF Margin % is 0.00%. Based on the distribution chart, Cleo Diagnostics ranks #999999 out of 815 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Cleo Diagnostics has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Cleo Diagnostics' FCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Cleo Diagnostics ranks #999999 out of 815 companies for FCF Margin %. This places Cleo Diagnostics in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Cleo Diagnostics and its competitors. Cleo Diagnostics's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cleo Diagnostics stock overvalued right now?
Cleo Diagnostics (ASX:COV) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Cleo Diagnostics' overall GF Score™ is 17/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Cleo Diagnostics (ASX:COV), the current FCF Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cleo Diagnostics Business Description

Address 480 Collins Street, Level 2, Melbourne, VIC, AUS, 3000
Cleo Diagnostics Ltd is focused on the development of non-invasive blood-based IVD tests to detect the presence, and recurrence, of ovarian cancer. The company's first product to market is intended to be the Triage Test which results to accurately differentiate patients with malignant ovarian cancer from those with benign gynecological conditions. The company aims to improve the diagnostic process and procedures for detecting ovarian cancer and, in this regard, improve quality-of-life outcomes for patients who have been diagnosed with ovarian cancer.
17GF Score

Get the complete analysis for ASX:COV

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.48
Price